Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann M Behre

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic HypogonadismR Ravi Shankar, Suneri Shah, Hee-Koung Joeng, et al.
European Urology|September 3, 2008
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendationsChristina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Andrology|September 20, 2023
Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelinesChristina Wang, Maria Cristina Meriggiola, John K Amory, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2016
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for MenHermann M Behre, Michael Zitzmann, Richard A Anderson, et al.
The Journal of Clinical Investigation|January 2, 2024
Human fertilization in vivo and in vitro requires the CatSper channel to initiate sperm hyperactivationSamuel Young, Christian Schiffer, Alice Wagner, et al.
Human Reproduction (Oxford, England)|June 23, 2016
Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic studyManuela Simoni, Daniele Santi, Luciano Negri, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Male hormonal contraception: a double-blind, placebo-controlled studyEllen Mommers, Wendy M Kersemaekers, Jörg Elliesen, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic HypogonadismR Ravi Shankar, Suneri Shah, Hee-Koung Joeng, et al.
European Urology|September 3, 2008
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendationsChristina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Andrology|September 20, 2023
Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelinesChristina Wang, Maria Cristina Meriggiola, John K Amory, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2016
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for MenHermann M Behre, Michael Zitzmann, Richard A Anderson, et al.
The Journal of Clinical Investigation|January 2, 2024
Human fertilization in vivo and in vitro requires the CatSper channel to initiate sperm hyperactivationSamuel Young, Christian Schiffer, Alice Wagner, et al.
Human Reproduction (Oxford, England)|June 23, 2016
Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic studyManuela Simoni, Daniele Santi, Luciano Negri, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Male hormonal contraception: a double-blind, placebo-controlled studyEllen Mommers, Wendy M Kersemaekers, Jörg Elliesen, et al.
Pageof 6